{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-115315","form_type":"8-K","ticker":"SENS","cik":"0001616543","company_name":"Senseonics Holdings, Inc.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.994473+00:00","generated_at":"2026-05-30T03:35:35.027044+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Senseonics Q3 revenue $4.3M, gross loss $4.1M; Eversense 365 launch underway","bullets":["Total revenue $4.3M, down ~30% YoY from $6.1M; U.S. revenue $2.4M vs $3.9M.","Gross loss $4.1M vs gross profit $1.2M, driven by $4.8M one-time charges for Eversense 365 transition.","Net loss $24.0M ($0.04/share), essentially flat vs $24.1M in Q3 2023.","Cash $74.8M, debt $55.9M; raised $16M post-quarter; FY2024 revenue guidance ~$22M.","FDA approved Eversense 365 (365-day CGM); first commercial insertion at Mercy; restructuring targets $10M cash OPEX cut in 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-115315","json":"https://secwatch.observer/filing/0001104659-24-115315.json","markdown":"https://secwatch.observer/filing/0001104659-24-115315.md","text":"https://secwatch.observer/filing/0001104659-24-115315.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924115315/0001104659-24-115315-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924115315/tm2427654d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:35:35.027044+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}